EN HU

Méhes Gábor

Publication list

Uploaded publications:
267
Publications in DEA:
267
OA:
102
Date range:
1993-2025
2025
1.
Vida, B., Török, O., Krasznai, Z. T., Buczkó, Z., Juhász, P., Méhes, G., Orosz, M., Jakab, A., Deli, T.: Placental insufficiency irrespective of offspring karyotype in maternal Turner syndrome: a case series and literature review.
Arch. Endocrinol. Metab. 69 (1), 1-8, (article identifier: 240144), 2025.
Journal metrics:
Q3 Endocrinology, Diabetes and Metabolism (2023)
2024
2.
Méhes, G., Mokánszki, A., Ujfalusi, A., Hevessy, Z., Miltényi, Z., Gergely, L., Bedekovics, J.: Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: tracing the Paths to Leukemic Transformation.
Int. J. Mol. Sci. 25 (14), 1-12, (article identifier: 8003), 2024.
Journal metrics:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
3.
Radványi, Á., Gyurina, K., Rácz, E., Kovács, I., Méhes, G., Röszer, T.: Adipose Tissue Macrophages of the Human Fetus.
Cells. 13 (21), 1-16, (article identifier: 1787), 2024.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
4.
Magyar, E., Ujfalusi, A., Czenke, M., Méhes, G.: A JAK2 szomatikus génmutáció lehetséges betegségmódosító hatása a cardiovascularis kórképek kialakulásában = Somatic JAK2 gene mutation is an evolving risk factor in cardiovascular diseases.
Orv. hetil. 165 (23), 883-890, 2024.
Journal metrics:
Q4 Medicine (miscellaneous) (2023)
5.
Chang Chien, Y. C., Mokánszki, A., Kollár, S., Méhes, G., Emri, G.: A PRAME diagnosztikai jelentősége Clear Cell Sarcomában: Esetismertetés.
Bőrgyógyász. venerol. szle. 100 (5), 241-245, 2024.
6.
Brúgós, B., Simon, Z., Méhes, G., Illés, Á., Pfliegler, G.: Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary.
Pathol. Oncol. Res. 30, 1-10, (article identifier: 1611785), 2024.
Journal metrics:
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Oncology (2023)
Q2 Pathology and Forensic Medicine (2023)
7.
Bicskó, R. R., Illés, Á., Hevessy, Z., Ivády, G., Kerekes, G., Méhes, G., Csépány, T., Gergely, L.: Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis.
Hematol Rep. 16 (2), 255-259, 2024.
Journal metrics:
Q4 Hematology (2023)
8.
Bedekovics, J., Madarász, K., Mokánszki, A., Deliné Molnár, S., Mester, Á., Miltényi, Z., Méhes, G.: Exploring p53 protein expression and its link to TP53 mutation in myelodysplasia-related malignancies - Interpretive challenges and potential field of applications.
Histopathology. [Epub ahead of print], 2024.
Journal metrics:
Q1 Histology (2023)
Q1 Medicine (miscellaneous) (2023)
D1 Pathology and Forensic Medicine (2023)
9.
Kurdi, N., Mokánszki, A., Balogh, I., Ujfalusi, A., Szabó, S., Méhes, G., Bedekovics, J.: Extracranial metastatic oligodendroglioma with molecular progression, case presentation.
Diagn. Pathol. 19 (1), 1-8, (article identifier: 103), 2024.
10.
Hudák, R., Szegedi, I., Petrás, M., Gaál, Z., Macsi, L., Szakszon, K., Merő, G., Nagy, O., Balogh, I., Bedekovics, J., Méhes, G., Baráth, S., Kiss, C.: Generalizált lymphadenopathia hátterében álló ritka ok: esetismertetés.
Gyermekgyógyászat. 75 (5), 365, 2024.
11.
Kalló, G., Zaman, K., Potor, L., Hendrik, Z., Méhes, G., Tóth, C., Gergely, P., Tőzsér, J., Balla, G., Balla, J., Prokai, L., Csősz, É.: Identification of Protein Networks and Biological Pathways Driving the Progression of Atherosclerosis in Human Carotid Arteries Through Mass Spectrometry-Based Proteomics.
Int. J. Mol. Sci. 25 (24), 1-21, (article identifier: 13665), 2024.
Journal metrics:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
12.
Köröskényi, K., Sós, L., Rostás, M., Papp, A. B., Kókai, E., Garabuczi, É., Deák, D., Beke, L., Méhes, G., Szondy, Z.: Loss of MER Tyrosine Kinase Attenuates Adipocyte Hypertrophy and Leads to Enhanced Thermogenesis in Mice Exposed to High-Fat Diet.
Cells. 13 (22), 1-20, (article identifier: 1902), 2024.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
13.
Virga, B., Pinczés, L. I., Illés, Á., Miltényi, Z., Magyari, F., Méhes, G., Simon, Z.: Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: a Single-Centre Experience.
Cureus. 16 (6), 1-10, (article identifier: 63307), 2024.
14.
Struzinská, I., Hájková, N., Hojny, J., Krkavcová, E., Michálková, R., Bui, Q. H., Matej, R., Laco, J., Drozenová, J., Fabian, P., Škapa, P., Špůrková, Z., Cibula, D., Frühauf, F., Jirásek, T., Zima, T., Méhes, G., Kendall Bártů, M., Nĕmejcová, K., Dundr, P.: Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas.
J. Mol. Diagn. 26 (4), 257-266, 2024.
Journal metrics:
Q1 Molecular Medicine (2023)
Q1 Pathology and Forensic Medicine (2023)
15.
Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L. C., Bajusz, D., Sipos, A., Petri, L., Szalai, T. V., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N. C., Jakab, F., Keserű, G. M., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
Journal metrics:
D1 Pharmacology (2023)
16.
Tóth, L. J., Mokánszki, A., Méhes, G.: The rapidly changing field of predictive biomarkers of non-small cell lung cancer.
Pathol. Oncol. Res. 30, 1-27, (article identifier: 1611733), 2024.
Journal metrics:
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Oncology (2023)
Q2 Pathology and Forensic Medicine (2023)
2023
17.
Nĕmejcová, K., Safanda, A., Bártủ, M., Michálková, R., Drozenová, J., Fabian, P., Hausnerová, J., Laco, J., Matej, R., Méhes, G., Škapa, P., Struzinská, I., Dundr, P.: A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Diagn. Pathol. 18 (1), 1-12, 2023.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Histology
Q2 Pathology and Forensic Medicine
18.
Nĕmejcová, K., Bártủ, M., Michálková, R., Drozenová, J., Fabian, P., Fadare, O., Hausnerová, J., Laco, J., Matej, R., Méhes, G., Singh, N., Stolnicu, S., Škapa, P., Svajdler, M., Struzinská, I., Cibula, D., Kocian, R., Lax, S. F., McCluggage, W. G., Dundr, P.: A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Diagn. Pathol. 18 (1), 1-10, (article identifier: 15), 2023.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Histology
Q2 Pathology and Forensic Medicine
19.
Struzinská, I., Hájková, N., Hojny, J., Krkavcová, E., Michálková, R., Dvorak, J., Nĕmejcová, K., Matej, R., Laco, J., Drozenová, J., Fabian, P., Hausnerová, J., Méhes, G., Škapa, P., Svajdler, M., Cibula, D., Frühauf, F., Bártủ, M., Dundr, P.: A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Diagn. Pathol. 18 (1), 1-12, (article identifier: 72), 2023.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Histology
Q2 Pathology and Forensic Medicine
20.
Juhász, P., Hasulyó, D., Bedekovics, J., Beke, L., Kacsala, N., Török, M., Méhes, G.: Carbonic Anhydrase IX (CAIX) Expressing Hypoxic Micro-environment Hampers CD8+ Immune Cell Infiltrate in Breast Carcinoma.
Appl. Immunohistochem. Mol. Morphol. 31 (1), 26-32, 2023.
Journal metrics:
Q3 Histology
Q2 Medical Laboratory Technology
Q2 Pathology and Forensic Medicine
21.
Bádon, E. S., Beke, L., Mokánszki, A., András, C., Méhes, G.: Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy.
Int. J. Mol. Sci. 24 (3), 1-16, (article identifier: 2581), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
22.
Bádon, E. S., Mokánszki, A., Mónus, A., András, C., Méhes, G.: Clonal diversity in KRAS mutant colorectal adenocarcinoma under treatment: Monitoring of cfDNA using reverse hybridization and DNA sequencing platforms.
Mol. Cell. Probes. 67, 1-8, (article identifier: 101891), 2023.
Journal metrics:
Q3 Cell Biology
Q3 Molecular Biology
23.
Kovács, Á. É., Csernátony, Z., Csámer, L., Méhes, G., Szabó, D., Veres, M., Braun, M., Harangi, B., Serban, N., Zhang, L., Falk, G., Soósné Horváth, H., Manó, S.: Comparative Analysis of Bone Ingrowth in 3D-Printed Titanium Lattice Structures with Different Patterns.
Materials. 16 (10), 1-16, (article identifier: 3861), 2023.
Journal metrics:
Q2 Condensed Matter Physics
Q2 Materials Science (miscellaneous)
24.
Kárteszi, J., Ziegler, A., Tihanyi, M., Elmont, B., Zhang, Y., Patócs, B., Molnár, M. J., Méhes, G., Wells, K., Jakus, R., Bessenyei, B., Ranatunga, W., Morava, É.: Compound heterozygous variants in MAPK8IP3 were detected in severe congenital hypotonia mimicking lethal spinal muscular atrophy.
Am. J. Med. Genet. A. 191 (9), 2428-2432, 2023.
Journal metrics:
Q2 Genetics
Q3 Genetics (clinical)
25.
Csoma, S. L., Madarász, K., Chang Chien, Y. C., Emri, G., Bedekovics, J., Méhes, G., Mokánszki, A.: Correlation Analyses between Histological Staging and Molecular Alterations in Tumor-Derived and Cell-Free DNA of Early-Stage Primary Cutaneous Melanoma.
Cancers (Basel). 15 (21), 1-13, (article identifier: 5141), 2023.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
DEENK University of Debrecen
© 2012 University of Debrecen